Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1981;64:1150-1156

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moss, A. J.
Right arrow Articles by Odoroff, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moss, A. J.
Right arrow Articles by Odoroff, C. L.

Circulation, Vol 64, 1150-1156, Copyright © 1981 by American Heart Association


ARTICLES

Digitalis-associated cardiac mortality after myocardial infarction

AJ Moss, HT Davis, DL Conard, JJ DeCamilla and CL Odoroff

The effect of digitalis therapy on 4-month posthospital cardiac mortality was investigated in 812 patients who survived the hospital phase of acute myocardial infraction. A stepwise multiple logistic regression analysis was used to identify variables associated with increased mortality and to adjust for differences in confounding variables between digitalis and nondigitalis patients. The major 4- month mortality (10 of 26 patients [38.5%]) occurred in digitalis- treated patients with congestive heart failure in the coronary care unit and complex ventricular premature depolarizations (VPDs) on the predischarge Holter recording. Logistic analyses that controlled for confounding variables indicated that digitalis use contributed to the increased mortality rate in this high-risk subset. The predicted mortality difference due to digitalis in patients with congestive heart failure and complex VPDs, adjusted for relevant nondigitalis risk factor variables, was 30% (90% confidence interval 18-42%). This retrospective study suggests that digitalis use increases the early posthospital mortality of myocardial infarction patients with combined electrical and mechanical dysfunction.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. Bartel, H. Vanheiden, J. Schaar, W. Mertzkirch, and R. Erbel
Biomechanical modeling of hemodynamic factors determining bulging of ventricular aneurysms
Ann. Thorac. Surg., November 1, 2002; 74(5): 1581 - 1587.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. Packer
End of the Oldest Controversy in Medicine -- Are We Ready to Conclude the Debate on Digitalis?
N. Engl. J. Med., February 20, 1997; 336(8): 575 - 576.
[Full Text]


Home page
NEJMHome page
K. Swedberg, H. Wedel, D. Neely, A. Schwartz, A. M. Feldman, M. R. Bristow, W. W. Parmley, and M. Packer
Vesnarinone for Heart Failure
N. Engl. J. Med., January 6, 1994; 330(1): 64 - 66.
[Full Text]


Home page
NEJMHome page
A. M. Feldman, M. R. Bristow, W. W. Parmley, P. E. Carson, C. J. Pepine, E. M. Gilbert, J. E. Strobeck, G. H. Hendrix, E. R. Powers, R. P. Bain, et al.
Effects of Vesnarinone on Morbidity and Mortality in Patients with Heart Failure
N. Engl. J. Med., July 15, 1993; 329(3): 149 - 155.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
P. R. Pagley, J. Yarzebski, R. Goldberg, Z. Chen, D. Chiriboga, P. Dalen, J. Gurwitz, J. S. Alpert, and J. M. Gore
Gender Differences in the Treatment of Patients With Acute Myocardial Infarction: A Multihospital, Community-Based Perspective
Arch Intern Med, March 8, 1993; 153(5): 625 - 629.
[Abstract] [PDF]


Home page
JAMAHome page
A. M. Feldman
Can We Alter Survival in Patients With Congestive Heart Failure?
JAMA, April 8, 1992; 267(14): 1956 - 1961.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
W. Klein, B. Eber, and B. Rotman
Comparative Effects of Digoxin and Xamoterol on Arrhythmias in Patients with Mild to Moderate Heart Failure
Angiology, April 1, 1992; 43(4): 281 - 286.
[Abstract] [PDF]


Home page
JAMAHome page
The Captopril-Digoxin Multicenter Research Group, J. Cohn, M. Hawkins, H. Levine, J. Naughton, E. Rapaport, S. Goldstein, B. Pitt, S. Goldstein, R. Cody, et al.
Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart Failure
JAMA, January 22, 1988; 259(4): 539 - 544.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
Cardiovascular Diseases: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers
Ann Intern Med, May 1, 1983; 98(5_Part_1): 679 - 685.
[Abstract] [PDF]